Support Alert

Class 4 medicines defect information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe

The Medicines and Healthcare products Regulatory Agency (MHRA) has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate.

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society